Top-level heading

Seminario Nasca e Bigio

MERCOLEDI' 23 Luglio ore 15.00  Aula C Edificio Farmacologia Dip. V. Erspamer
 

DOTT.SSA CARLA NASCA

Laboratory of Neuroendocrinology, The Rockfeller University, New York
"The mGlu2 metabotropic glutamate receptor is a key mediator in the response to next-generation antidepressant treatments: epigenetic mechanisms of stress susceptibility".
 

DOTT.SSA BETTY BIGIO

Center for clinical and Translational Science, The Rockfeller university, New York
"GWAS as a novel computational discovery tool for diseases: implications for autism".

Data notizia